Stockscreener 앱 받기
43.17
1.18%
0.5025
시간 외 거래:
43.17
0.0037
+0.01%
전일 마감가:
$42.66
열려 있는:
$42.76
하루 거래량:
16,731
Relative Volume:
0.61
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.08%
1개월 성능:
+5.51%
6개월 성능:
+16.41%
1년 성능:
+61.64%
1일 변동 폭
$42.65
$43.44
1주일 범위
$41.86
$43.51
52주 변동 폭
$26.24
$43.51
Tema Oncology Etf Stock (CANC) Company Profile
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
43.17 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
382.13 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
772.67 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
776.29 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
307.97 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
729.87 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf 주식(CANC)의 최신 뉴스
(CANC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Anders Storm Appointed Expert Advisor to Tema Photonics & Optical ETF (LAZR) - businesswire.com
TEMA ONCOLOGY ETF (CANC) Stock Chart - ChartMill
Price-Driven Insight from (CANC) for Rule-Based Strategy - Stock Traders Daily
ETFs Investing in BridgeBio Oncology Therapeutics, Inc. Stocks - TradingView
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years - The National Law Review
BridgeBio Oncology Therapeutics Ord Shs (BBOT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Memory Giant CXMT Becomes a Top Holding in Tema Memory ETF (DISK) - Business Wire
ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView
CG Oncology Inc (CGON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(CANC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Tema Launches Healthcare AI ETF (HLTH) - Tema ETFs
CANC ETF Profile: Dividends, Returns (BOATS:CANC) - TradingView
CANC ETF Profile: Dividends, Returns (NASDAQ:CANC) - TradingView
CANCTema Oncology ETF Earnings - Finviz
(CANC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Tema ETFs and SemiAnalysis Launch Exclusive Semiconductor ETF Partnership - Tema ETFs
(CANC) Risk Channels and Responsive Allocation - Stock Traders Daily
Ascentage Pharma Group International (AAPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcellx Inc (ACLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Merus NV (MRUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Helix Acquisition Corp II (HLXB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(CANC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Liquidity Mapping Around (CANC) Price Events - Stock Traders Daily
CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Why (CANC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Understanding Momentum Shifts in (CANC) - Stock Traders Daily
Pancreatic Cancer's Turning Point, and the RAS Revolution Ahead - Tema ETFs
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
Tema ETFs Announces Product Updates - Tema ETFs
Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily
Tema Electrification ETF (VOLT) Surpasses $500 Million in AUM - Tema ETFs
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha
CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha
Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily
Tema Launches First Pure-Play Space ETF to Offer SpaceX Exposure - Tema ETFs
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Electrification is an American Story - Tema ETFs
Biotech stocks and longevity investing: Trends to track - North Scott Press
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Tema ETFs
Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga
Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - moneyandbanking.co.th
Tema Oncology Etf (CANC) 재무 분석
Tema Oncology Etf (CANC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.53%
자본화:
|
볼륨(24시간):